DE60116889D1 - Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe

Info

Publication number
DE60116889D1
DE60116889D1 DE60116889T DE60116889T DE60116889D1 DE 60116889 D1 DE60116889 D1 DE 60116889D1 DE 60116889 T DE60116889 T DE 60116889T DE 60116889 T DE60116889 T DE 60116889T DE 60116889 D1 DE60116889 D1 DE 60116889D1
Authority
DE
Germany
Prior art keywords
test
body fluid
inflammatory
direct evidence
inflammatory indicator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60116889T
Other languages
English (en)
Other versions
DE60116889T2 (de
Inventor
Rud Lassen
Morten Breindahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BESST TEST APS LYNGBY
Original Assignee
BESST TEST APS LYNGBY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BESST TEST APS LYNGBY filed Critical BESST TEST APS LYNGBY
Application granted granted Critical
Publication of DE60116889D1 publication Critical patent/DE60116889D1/de
Publication of DE60116889T2 publication Critical patent/DE60116889T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60116889T 2000-10-17 2001-10-12 Test zum direkten nachweis eines inflammatorischen anzeigers ein einer körperflüssigkeitsprobe Expired - Fee Related DE60116889T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001550 2000-10-17
DK200001550 2000-10-17
US24217600P 2000-10-23 2000-10-23
US242176P 2000-10-23
PCT/DK2001/000674 WO2002033408A1 (en) 2000-10-17 2001-10-12 Assay for directly detecting an inflammatory indicator in a body fluid sample

Publications (2)

Publication Number Publication Date
DE60116889D1 true DE60116889D1 (de) 2006-04-13
DE60116889T2 DE60116889T2 (de) 2006-09-14

Family

ID=26068897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116889T Expired - Fee Related DE60116889T2 (de) 2000-10-17 2001-10-12 Test zum direkten nachweis eines inflammatorischen anzeigers ein einer körperflüssigkeitsprobe

Country Status (8)

Country Link
US (1) US20040048274A1 (de)
EP (1) EP1340077B1 (de)
JP (1) JP2004511802A (de)
AT (1) ATE316653T1 (de)
AU (1) AU2001295442A1 (de)
DE (1) DE60116889T2 (de)
ES (1) ES2257446T3 (de)
WO (1) WO2002033408A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072237A1 (en) * 2001-12-26 2004-04-15 Barry Schweitzer Use of cytokines secreted by dendritic cells
KR101071430B1 (ko) * 2002-08-27 2011-10-10 킴벌리-클라크 월드와이드, 인크. 시분해 형광을 이용한 막 기반 분석법
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
ATE529750T1 (de) * 2005-07-28 2011-11-15 Vittorio Enrico Avvedimento Stimulatorische autoantikörper gegen den pdgf- rezeptor als pathologische marker und therapeutisches target
WO2007015128A1 (en) * 2005-08-02 2007-02-08 Xbiotech Inc. DIAGNOSIS, TREATMENT, AND PREVENTION OF VASCULAR DISORDERS USING IL-1α AUTOANTIBODIES
GB0616238D0 (en) 2006-08-15 2006-09-27 Inst Animal Health Ltd Diagnostic Test
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100137247A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
EP2745114B1 (de) 2011-09-16 2018-10-17 Credo Biomedical Pte Ltd. Molekulare diagnostische testvorrichtung und verwendungsverfahren
US8852873B2 (en) 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes
EP2902783B1 (de) * 2012-09-28 2017-08-30 Sekisui Medical Co., Ltd. Additiv zur messung einer verdünnten probe in einem reagens einer immunchromatografischen methode ohne verdünnung
CA2895096A1 (en) * 2012-12-20 2014-06-26 Novartis Ag Acute kidney injury
CN103105489B (zh) * 2013-01-23 2014-12-24 深圳市亚辉龙生物科技有限公司 检测自身免疫性疾病抗体的免疫印迹试剂盒及其制备方法
CN104764882A (zh) * 2014-08-20 2015-07-08 苏州和锐医药科技有限公司 一种抗bpi-anca抗体检测试纸条的制备方法及应用
WO2017064555A1 (en) * 2015-10-05 2017-04-20 Seinda Biomedical Corporation Methods and devices for diagnosing ocular surface inflammation anddry eye disease
CN107389925B (zh) * 2017-07-28 2019-03-29 上海交通大学医学院附属上海儿童医学中心 用于脓毒症快速诊断的il-6和il-10二联胶体金免疫层析试剂盒
GB202004972D0 (en) * 2020-04-03 2020-05-20 Neutrocheck Ltd Blood analysis method
CN112946259A (zh) * 2021-02-02 2021-06-11 瑞莱生物科技江苏有限公司 降钙素原、白介素6和肝素结合蛋白联合检测试剂盒
CN116068207A (zh) * 2023-03-24 2023-05-05 山东康华生物医疗科技股份有限公司 一种用于检测nk细胞活性的试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
DE69031912D1 (de) * 1989-06-06 1998-02-12 Ampcor Inc Reagenziensatz für immunoassay
DE69230000T2 (de) * 1991-07-19 2000-05-11 Cytimmune Sciences, Inc. Verfahren und testsatz zur messung von endogenen zytokinen
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis
US7074399B2 (en) * 2000-02-18 2006-07-11 Vanderbilt University Treatment of inflammation with p20
ATE403153T1 (de) * 2000-10-17 2008-08-15 Besst Test Aps Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Also Published As

Publication number Publication date
US20040048274A1 (en) 2004-03-11
EP1340077A1 (de) 2003-09-03
DE60116889T2 (de) 2006-09-14
JP2004511802A (ja) 2004-04-15
WO2002033408A1 (en) 2002-04-25
ES2257446T3 (es) 2006-08-01
EP1340077B1 (de) 2006-01-25
AU2001295442A1 (en) 2002-04-29
ATE316653T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
DE60116889D1 (de) Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
CA2465800A1 (en) Instrument
ATE489633T1 (de) Verfahren zum frühzeitigen nachweis herzerkrankungen
ATE256869T1 (de) Probendetektion zum initiieren der zeitmessung eines elektrochemischen tests
ATE510208T1 (de) Probenanalyseverfahren und probenanalyseeinrichtung
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
WO2003011108A3 (en) Access pressure ratio device and testing method
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
EP1519190A3 (de) Flüssigkeitssensoreinrichtung zur dynamischen Prüfung von Flüssigkeiten
CN102221473A (zh) 一种起重机主金属结构剩余疲劳寿命的估算方法
WO2000074553A3 (en) Gas analyzer calibration checking device
BR9915637A (pt) Dispositivo de medição de múltiplos produtos quìmicos e tiras de teste
DE50214912D1 (de) Verfahren zum bestimmen von eigenschaften eines koordinatenmessgeräts sowie testobjekt hierzu
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
SE0100983D0 (sv) Metod och anordning vid täthetsprovning och läcksökning
ATE541048T1 (de) Verfahren und vorrichtung zum nachweisen und/oder bestimmen der in einer probe enthaltenen bakterien
ATE528102T1 (de) Verfahren zum prüfen einer rotationsachse mit einer selbstzentrierenden messvorrichtung
Choi et al. An experimental study on damage detection of structures using a timber beam
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
Spyrakos et al. Evaluating structural deterioration using dynamic response characterization
FI20030992A (fi) Menetelmä hydrometeoreja havaitsevan mittalaitteen yhteydessä sekä tähän liittyvä laitteisto
ATE451676T1 (de) Gasmeldeeinrichtung und verfahren zum überprüfen einer solchen
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
DE602004021673D1 (de) Verfahren und vorrichtungen zur gewichtsmessung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee